What are the payment terms?

Payment terms include LC, T/T, D/P, PayPal, Western Union, Small-amount payment, Money Gram, and cash.

What is the average lead time?

Peak season lead time is one month, while off-season lead time is within 15 workdays.

Which markets do you export to?

Main markets include North America, South America, Eastern Europe, Southeast Asia, Africa, Oceania, Mid East, Eastern Asia, and Western Europe.

Sida Cordifolia P. E. Plant Extract High Quality

Name: Sida Cordifolia P. E. Plant Extract High Quality
Brand: Puyer Biopharma Ltd.
SKU: 2150592415

Jiangsu, ChinaPuyer Biopharma Ltd.

US$15.00-35.00

1 kg

Sample price:US$50.00/piece.Request sample

Product profile

Customization

Available

CAS No.

N/a

Formula

N/a

Model NO.

plant extract

EINECS

N/a

Packaging Material

Paper

Storage Method

Normal

Shelf Life

>12 Months

Nutrient Composition

Plant Extract

Resource

Natural

The content of active substances

＞90%

Transport Package

Drum

Specification

99%

Trademark

PUYER

Origin

China

Production Capacity

100000kg/Month

Key features

High Active Content: Active substance content is greater than 90% for high purity.

Long Shelf Life: Shelf life exceeds 12 months when stored under normal conditions.

Natural Resource: Derived from natural plant sources with no artificial additives.

Antioxidant Benefits: Rich in polyphenols and carotenoids to neutralize free radicals.

Antimicrobial Action: Inhibits bacteria, fungi, and viruses for natural preservation.

Anti-Inflammatory Effects: Helps reduce inflammation for managing arthritis and disorders.

Cardiovascular Support: Aids heart health by reducing blood pressure and cholesterol.

Versatile Applications: Suitable for nutraceuticals, food additives, and animal nutrition.

Company profile

Puyer Biopharma Ltd.

Jiangsu, China

Business Type: Manufacturer/Factory, Trading Company, OtherExport Year: 2016-08-01Nearest Port: shanghai, qingdao, tianjinAverage Response Time: ≤9.68hTerms of Payment: LC, T/T, D/P, etc.International Commercial Terms(Incoterms): FOB, CFR, CIF, DAT, FAS, DDP, DAP, CIP, CPT, FCA, EXW

AI-Powered supplier vetting

SummaryPuyer Biopharma Ltd. is identified as a China-based limited company operating from Nantong, Jiangsu, with manufacturer/factory and trading-company classifications. Its stated scope covers APIs, intermediates, fine chemicals, nutraceuticals, crop science, animal health, and related services. Evidence indicates ISO 9001 certification, 21–30 years of combined R&D engineer experience, 6–10 quality-control staff, 10 production lines, batch production of more than 300 products, and multiple production or testing locations. The supplier exports independently, began exporting in 2016, and reports broad international market coverage. However, the provided information does not establish after-sales service processes, financial credibility, customization execution, or named customer cases. Indexes 8 and 9 identify a different entity, Tieling Municipal People’s Government, and are excluded from supplier conclusions.

Supplier typeThe supplier is described as a factory, manufacturer, and trading company. Puyer Biopharma Ltd. is a China-based limited company located in Nantong, Jiangsu, and its stated business covers production, R&D, and sales of pharmaceutical, chemical, nutrition, agricultural, and related products.

CertificationsThe supplier explicitly reports ISO 9001 certification for its management system. This provides direct evidence of a recognized quality-management certification, although no additional certifications are stated.

R&D capabilityPuyer is described as a high-tech enterprise founded by doctors and specializing in R&D, with 21–30 years of R&D engineer experience. It reports laboratories, testing centers, production bases, and investment in R&D testing and production equipment, directly supporting substantial innovation and technical-development capability.

Production capacityThe supplier reports 10 production lines, batch production of more than 300 products, multiple production bases, and stated annual capacities for salicylic acid, potassium humate, amino acid powder, dicalcium phosphate, and choline chloride. These figures provide explicit evidence of broad and sizable production capability.